BICX insider trading
OTC Markets OTCPK HealthcareBioCorRx Inc.: insider trade history from SEC Form 4 filings.
About BioCorRx Inc.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of alcohol and opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.
Company website: www.biocorrx.com
BICX insider activity at a glance
FilingIQ tracks 177 insider transactions for BICX in filings since Feb 10, 2015. The most recent transaction is dated Dec 31, 2024.
Across the full history, 31 open-market purchases
and 13 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest BICX Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BICX?
- FilingIQ tracks 177 Form 4 insider transactions for BICX (BioCorRx Inc.), covering filings from Feb 10, 2015 onwards. 0 of those are dated within the last 90 days.
- Are BICX insiders net buyers or net sellers?
- Across the full Form 4 history for BICX, 31 transactions (18%) were open-market purchases and 13 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BICX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is BICX in?
- BioCorRx Inc. (BICX) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $9.47M.
Methodology & sources
Every BICX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.